Canada-based Genesys Capital launched a fund with a first close over $30M targeting up to $40M to back early-stage life sciences startups translating university research across biotechnology, pharmaceuticals, and medical technology.
08/28/2026
MassMutual Ventures
<p>Springfield, MA-based <a...



